{
    "PMC": "5926972",
    "DOI": "10.1111/j.1349-7006.2002.tb02173.x",
    "PMID": "11927013",
    "PMCID": "PMC5926972",
    "title": "Evaluation of an indicator for lymph node metastasis of esophageal squamous cell carcinoma invading the submucosal layer.",
    "year": 2002,
    "source_url": "https://europepmc.org/article/PMC/PMC5926972",
    "source": "MED",
    "abstract_text": "Lymph node metastasis is a major prognostic factor for esophageal squamous cell carcinoma (ESCC). In recent years, endoscopic mucosal resection (EMR) has been developed with excellent results for the treatment of the superficial ESCC. To make the EMR treatment successful, it is important to establish a good indicator to identify ESCC patients at a high risk of lymph node metastasis. In this study, we examined clinicopathological and immunohistochemical factors to investigate the factors involved in lymph node metastasis of ESCC invading to the submucosal layer (sm-ESCC). Surgical specimens from 84 sm-ESCC patients were examined. Among 84 sm-ESCC patients, 33 (39.3%) had lymph node metastases. Clinicopathologically, tumor depth, lymphatic invasion and blood vessel invasion showed significant correlations with lymph node metastasis by univariate analysis. Tumor depth and lymphatic invasion showed significant correlations by multivariate analysis of these factors. Immunohistochemically, P53 accumulation was observed in 45 cases (53.6%), cyclin D1 overexpression in 25 (29.8%), and pRB in 65 (77.4%). P53 accumulation, cyclin D1 overexpression and MIB-1 Labeling Index were significantly associated with lymph node metastasis by univariate analysis, and P53 accumulation showed a significant correlation with lymph node metastasis by multivariate analysis. Among tumor depth, lymphatic invasion and P53 accumulation, tumor depth and lymphatic invasion were significantly correlated with lymph node metastasis (P = 0.0023 and P = 0.0092, respectively) by multivariate analysis. These data suggest that tumor depth and lymphatic invasion can be considered as good indicators for lymph node metastasis among patients with sm-ESCC. In addition, P53 accumulation could be helpful to identify the patients who need additional treatment after EMR.",
    "full_text": "Jpn J Cancer Res Jpn. J. Cancer Res 10.1111/(ISSN)1349-7006a CAS Japanese Journal of Cancer Research : Gann 0910-5050 1876-4673 Blackwell Publishing Ltd Oxford, UK 5926972 11927013 10.1111/j.1349-7006.2002.tb02173.x CAE305 Article Evaluation of an Indicator for Lymph Node Metastasis of Esophageal Squamous Cell Carcinoma Invading the Submucosal Layer Nakajima Yasuaki 1 Nagai Kagami 1 Miyake Satoshi 2 Ohashi Kenichi 3 Kawano Tatsuyuki 1 Iwai Takehisa 1 1 Department of Surgeryr 2 Department of Molecular Oncology and 3 Department of Pathology, Tokyo Medical and Dental University, 1\u20135\u201345 Yushima, Bunkyo\u2010ku, Tokyo 113\u20138519 * E\u2010mail: yasu.nakajima.srgl@tmd.ac.jp 3 2002 93 3 10.1111/cas.2002.93.issue-3 305 312 ( Received October 4, 2001/Revised December 25, 2001/Accepted January 11, 2002 ) Lymph node metastasis is a major prognostic factor for esophageal squamous cell carcinoma (ESCC). In recent years, endoscopic mucosal resection (EMR) has been developed with excellent results for the treatment of the superficial ESCC. To make the EMR treatment successful, it is important to establish a good indicator to identify ESCC patients at a high risk of lymph node metastasis. In this study, we examined clinicopathological and immunohistochemical factors to investigate the factors involved in lymph node metastasis of ESCC invading to the submucosal layer (sm\u2010ESCC). Surgical specimens from 84 sm\u2010ESCC patients were examined. Among 84 sm\u2010ESCC patients, 33 (39.3%) had lymph node metastases. Clinicopathologically, tumor depth, lymphatic invasion and blood vessel invasion showed significant correlations with lymph node metastasis by univariate analysis. Tumor depth and lymphatic invasion showed significant correlations by multivariate analysis of these factors. Immunohistochemically, P53 accumulation was observed in 45 cases (53.6%), cyclin D1 overexpression in 25 (29.8%), and pRB in 65 (77.4%). P53 accumulation, cyclin D1 overexpression and MIB\u20101 Labeling Index were significantly associated with lymph node metastasis by univariate analysis, and P53 accumulation showed a significant correlation with lymph node metastasis by multivariate analysis. Among tumor depth, lymphatic invasion and P53 accumulation, tumor depth and lymphatic invasion were significantly correlated with lymph node metastasis ( P =0.0023 and P =0.0092, respectively) by multivariate analysis. These data suggest that tumor depth and lymphatic invasion can be considered as good indicators for lymph node metastasis among patients with sm\u2010ESCC. In addition, P53 accumulation could be helpful to identify the patients who need additional treatment after EMR. Esophageal squamous cell carcinoma Submucosal layer Lymph node metastasis P53 source-schema-version-number 2.0 cover-date March 2002 details-of-publishers-convertor Converter:WILEY_ML3GV2_TO_NLMPMC version:4.6.9 mode:remove_FC converted:04.11.2015 REFERENCES 1 Endo , T. A research of factors determing the prognosis of patients with esophageal cancer using multivariate analysis\u2014by Cox's proportional hazards model . Jpn. J. Gastroenterol. Surg. , 25 , 1191 \u2013 1200 ( 1992 ). 2 Endo , M. and Kawano , T. Detection and classification of early squamous cell esophageal cancer . Dis. Esophagus , 10 , 155 \u2013 158 ( 1997 ). 9280071 3 Bogomoletz , W. V. , Molas , G. , Gayet , B. and Potet , F. Superficial squamous cell carcinoma of the esophagus\u2014a report of 76 cases and review of the literature . Am. J. Surg. Pathol. , 13 , 535 \u2013 546 ( 1989 ). 2660607 4 Ide , H. , Nogami , A. , Hanashi , T. , Endo , T. , Kubota , N. , Nakamura , T. , Muroi , M. , Eguchi , R. , Kobayashi , A. , Habu , F. , Yamada , A. and Murata , Y. A clinical study on prognosis of submucosal esophageal cancer . Stomach and Intestine , 25 , 1067 \u2013 1074 ( 1990 ) (in Japanese) . 5 Watanabe , H. , Tada , T. , Iwabuchi , M. , Ajioka , Y. and Motoyama , T. New definition and macroscopic characteristics of early carcinoma of the esophagus . Stomach and Intestine , 22 , 1075 \u2013 1086 ( 1990 ) (in Japanese) . 6 Goseki , N. , Koike , M. and Yoshida , M. Histopathologic characteristics of early stage esophageal carcinoma . Cancer , 69 , 1088 \u2013 1093 ( 1992 ). 1739905 7 Inoue , H. and Endo , M. Endoscopic esophageal mucosal resection using a transparent tube . Surg. Endosc. , 4 , 198 \u2013 201 ( 1990 ). 2291159 8 Kawano , T. , Miyake , S. , Yasuno , M. , Takamatsu , S. , Katoh , S. , Nakamura , H. , Sugihara , K. , Hatano , M. , Yoshino , K. , Takeshita , K. , Inoue , H. , Yamagiwa , A. and Endo , M. A new technique for endoscopic esophageal mucosectomy using a transparent overtube with intraluminal negative pressure (np\u2010EEM) . Dig. Endosc. , 3 , 159 \u2013 167 ( 1991 ). 9 Inoue , H. , Takeshita , K. , Hori , H. , Muraoka , Y. , Yoneshima , H. and Endo , M. Endoscopic mucosal resection with a cap\u2010fitted panendoscope for esophagus, stomach, and colon mucosal lesions . Gastrointest. Endosc. , 39 , 58 \u2013 62 ( 1993 ). 8454147 10 Japanese Society for Esophageal Diseases . \u201c Guide Lines for the Clinical and Pathologic Studies on Carcinoma of the Esophagus ,\u201d 9th Ed. , pp. 1 \u2013 93 ( 1999 ). 11 Nabeya , K. and Nakata , Y. Extent of resection and lymphadenectomy in early squamous cell esophageal cancer . Dis. Esophagus , 10 , 159 \u2013 161 ( 1997 ). 9280072 12 Tachibana , M. , Yoshimura , H. , Kinugasa , S. , Hashimoto , N. , Dhar , D. K. , Abe , S. , Monden , N. and Nagasue , N. Clinicopathological features of superficial squamous cell carcinoma of the esophagus . Am. J. Surg. , 174 , 49 \u2013 53 ( 1997 ). 9240952 13 Kodama , M. and Kakegawa , T. Treatment of superficial cancer of the esophagus: a summary of responses to a questionnaire on superficial cancer of the esophagus in Japan . Surgery , 123 , 432 \u2013 439 ( 1998 ). 9551070 14 Coggi , G. , Bosari , S. , Roncalli , M. , Graziani , D. , Bossi , P. , Viale , G. , Buffa , R. , Ferrero , S. , Piazza , M. , Blandamura , S. , Segalin , A. , Bonavina , L. and Peracchia , A. p53 protein accumulation and p53 gene mutation in esophageal carcinoma\u2014a molecular and immunohistochemical study with clinicopathologic correlations . Cancer , 79 , 425 \u2013 432 ( 1997 ). 9028350 15 Takeuchi , H. , Ozawa , S. , Ando , N. , Shih , C. H. , Koyanagi , K. , Ueda , M. and Kitajima , M. Altered p16/MTS1/CDKN2 and cyclin D1/PRAD\u20101 gene expression is associated with the prognosis of squamous cell carcinoma of the esophagus . Clin. Cancer Res. , 3 , 2229 \u2013 2236 ( 1997 ). 9815619 16 Xing , E. P. , Yang , G. Y. , Wang , L. D. , Shi , S. T. and Yang , C. S. Loss of heterozygosity of the Rb gene correlations with pRb protein expression and associates with p53 alteration in human esophageal cancer . Clin. Cancer Res. , 5 , 1231 \u2013 1240 ( 1999 ). 10353761 17 Greenblatt , M. S. , Bennett , W. P. , Hollstein , M. and Harris , C. C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis . Cancer Res. , 54 , 4855 \u2013 4878 ( 1994 ). 8069852 18 Ko , L. J. and Prives , C. p53: puzzle and paradigm . Genes Dev. , 10 , 1054 \u2013 1072 ( 1996 ). 8654922 19 Levine , A. J. P53, the cellular gatekeeper for growth and division . Cell , 88 , 323 \u2013 331 ( 1997 ). 9039259 20 Scheffner , M. , Werness , B. A. , Huibregtse , J. M. , Levine , A. J. and Howley , P. M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 . Cell , 63 , 1129 \u2013 1136 ( 1990 ). 2175676 21 Lane , D. P. and Crawford , L. T antigen is bound to a host protein in SV40 transformed cells . Nature , 278 , 261 \u2013 263 ( 1979 ). 218111 22 Linzer , D. I. and Levine , A. J. Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40\u2010transformed cells and uninfected embryonal carcinoma cells . Cell , 17 , 43 \u2013 52 ( 1979 ). 222475 23 Kao , C. C. , Yew , P. R. and Berk , A. J. Domains required for in vitro association between the cellular p53 and the adenovirus 2 E1B 55K proteins . Virology , 179 , 806 \u2013 814 ( 1990 ). 2146804 24 El\u2010Deiry , W. S. , Tokino , T. , Velculescu , V. E. , Levy , D. B. , Parsons , R. , Trent , J. M. , Lin , D. , Mercer , E. , Kinzler , K. W. and Vogelstein , B. WAF1, a potential mediator of p53 tumor suppression . Cell , 75 , 817 \u2013 825 ( 1993 ). 8242752 25 Lowe , S. W. , Schmitt , E. M. , Smith , S. W. , Osborne , B. A. and Jacks , T. p53 is required for radiation\u2010induced apoptosis in mouse thymocytes . Nature , 362 , 847 \u2013 849 ( 1993 ). 8479522 26 Clarke , A. R. , Purdie , C. A. , Harrison , D. J. , Morris , R. G. , Bird , C. C. , Hooper , M. L. and Wyllie , A. H. Thymocyte apoptosis induced by p53\u2010dependent and independent pathways . Nature , 362 , 849 \u2013 852 ( 1993 ). 8479523 27 Kastan , M. B. , Zhan , Q. , El\u2010Deiry , W. S. , Carrier , F. , Jacks , T. , Walsh , W. V. , Plunkett , B. S. , Vogelstein , B. and Fornace , A. J. , Jr. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxiatelangiectasia . Cell , 71 , 587 \u2013 597 ( 1992 ). 1423616 28 Wu , X. , Bayle , J. H. , Olson , D. and Levine , A. J. The p53\u2010 mdm\u20102 autoregulatory feedback loop . Genes Dev. , 7 , 1126 \u2013 1132 ( 1993 ). 8319905 29 Maki , C. G. , Huibregtse , J. M. and Howley , P. M. In vivo ubiquitination and proteasome\u2010mediated degradation of p53 . Cancer Res. , 56 , 2649 \u2013 2654 ( 1996 ). 8653711 30 Honda , R. , Tanaka , H. and Yasuda , H. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53 . FEBS Lett. , 420 , 25 \u2013 27 ( 1997 ). 9450543 31 Honda , R. and Yasuda , H. Association of p19 ARF with mdm2 inhibits ubiquitin ligase activity of mdm2 for tumor suppressor p53 . EMBO J. , 18 , 22 \u2013 27 ( 1999 ). 9878046 32 Baas , I. O. , Mulder , J. W. , Offerhaus , J. A. , Vogelstein , B. and Hamilton , S. R. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms . J. Pathol. , 172 , 5 \u2013 12 ( 1994 ). 7931827 33 Lambkin , H. A. , Mothersill , C. M. and Kelehan , P. Variations in immunohistochemical detection of p53 protein overexpression in cervical carcinomas with different antibodies and methods of detection . J. Pathol. , 172 , 13 \u2013 18 ( 1994 ). 7931822 34 Wynford\u2010Thomas , D. p53 in tumor pathology: can we trust immunohistochemistry ? J. Pathol. , 166 , 329 \u2013 330 ( 1992 ). 1517889 35 Shieh , S. Y. , Ikeda , M. , Taya , Y. and Prives , C. DNA damage\u2010induced phosphorylation of p53 alleviates inhibition by mdm2 . Cell , 91 , 325 \u2013 334 ( 1997 ). 9363941 36 Siliciano , J. D. , Canman , C. E. , Taya , Y. , Sakaguchi , K. , Appella , E. and Kastan , M. B. DNA damage induces phosphorylation of the amino terminus of p53 . Genes Dev. , 11 , 3471 \u2013 3481 ( 1997 ). 9407038 37 Kamijo , T. , Weber , J. D. , Zambetti , G. , Zindy , F. , Roussel , M. F. and Sherr , C. J. Functional and physical interactions of the ARF tumor suppressor with p53 and mdm2 . Proc. Natl. Acad. Sci. USA , 95 , 8292 \u2013 8297 ( 1998 ). 9653180 38 Shimaya , K. , Shinozaki , H. , Inoue , M. , Tahara , H. , Monden , T. , Shimano , T. and Mori , T. Significance of p53 expression as a prognostic factor in oesophageal squamous cell carcinoma . Virchows Arch. A Pathol. Anat. Histopathol. , 422 , 271 \u2013 276 ( 1993 ). 8506620 39 Sarbia , M. , Porscen , R. , Borchard , F. , Horstmann , O. , Willers , R. and Gabbert , H. E. p53 protein expression and prognosis in squamous cell carcinoma of the esophagus . Cancer , 74 , 2218 \u2013 2223 ( 1994 ). 7922972 40 Wang , D. Y. , Xiang , Y. Y. , Tanaka , M. , Li , X. R. , Li , J. L. , Shen , Q. , Sugimura , H. and Kino , I. High prevalence of p53 protein overexpression in patients with esophageal cancer in Linxian, China and its relationship to progression and prognosis . Cancer , 74 , 3089 \u2013 3096 ( 1994 ). 7982172 41 Ikeguchi , M. , Saito , H. , Katano , K. , Tsujitani , S. , Maeta , M. and Kaibara , N. Clinicopathologic significance of the expression of mutated p53 protein and the proliferative activity of cancer cells in patients with esophageal squamous cell carcinoma . J. Am. Coll. Surg. , 185 , 398 \u2013 403 ( 1997 ). 9328389 42 Inada , S. , Koto , T. , Futami , K. , Arima , S. and Iwashita , A. Evaluation of malignancy and the prognosis of esophageal cancer based on an immunohistochemical study (p53, E\u2010 cadherin, epidermal growth factor receptor) . Surg. Today , 29 , 493 \u2013 503 ( 1999 ). 10385363 43 Wang , L. S. , Chow , K. C. , Chi , K. H. , Liu , C. C. , Li , W. Y. , Chiu , J. H. and Huang , M. H. Prognosis of esophageal squamous cell carcinoma: analysis of clinicopathological and biological factors . Am. J. Gastroenterol. , 94 , 1933 \u2013 1940 ( 1999 ). 10406262 44 Kanamoto , A. , Kato , H. , Tachimori , Y. , Watanabe , H. , Nakanishi , Y. , Kondo , H. , Yamaguchi , H. , Gotoda , T. , Muro , K. and Matsumura , Y. No prognostic significance of p53 expression in esophageal squamous cell carcinoma . J. Surg. Oncol. , 72 , 94 \u2013 98 ( 1999 ). 10518106 45 Chyczewski , L. , Kozlowski , M. , Niklinski , J. , Szyszko , J. , Laudanski , J. and Niklinska , W. p53 protein expression in resected invasive esophageal cancer . Neoplasma , 46 , 150 \u2013 155 ( 1999 ). 10613589 46 Tajima , T. , Nakanishi , Y. , Ochiai , A. , Tachimori , Y. , Kato , H. , Watanabe , H. , Yamaguchi , H. , Yoshimura , K. , Kusano , M. and Shimoda , T. Histopathologic findings predicting lymph node metastasis and prognosis of patients with superficial esophageal carcinoma . Cancer , 88 , 1285 \u2013 1293 ( 2000 ). 10717608",
    "full_text_abstract": "Lymph node metastasis is a major prognostic factor for esophageal squamous cell carcinoma (ESCC). In recent years, endoscopic mucosal resection (EMR) has been developed with excellent results for the treatment of the superficial ESCC. To make the EMR treatment successful, it is important to establish a good indicator to identify ESCC patients at a high risk of lymph node metastasis. In this study, we examined clinicopathological and immunohistochemical factors to investigate the factors involved in lymph node metastasis of ESCC invading to the submucosal layer (sm\u2010ESCC). Surgical specimens from 84 sm\u2010ESCC patients were examined. Among 84 sm\u2010ESCC patients, 33 (39.3%) had lymph node metastases. Clinicopathologically, tumor depth, lymphatic invasion and blood vessel invasion showed significant correlations with lymph node metastasis by univariate analysis. Tumor depth and lymphatic invasion showed significant correlations by multivariate analysis of these factors. Immunohistochemically, P53 accumulation was observed in 45 cases (53.6%), cyclin D1 overexpression in 25 (29.8%), and pRB in 65 (77.4%). P53 accumulation, cyclin D1 overexpression and MIB\u20101 Labeling Index were significantly associated with lymph node metastasis by univariate analysis, and P53 accumulation showed a significant correlation with lymph node metastasis by multivariate analysis. Among tumor depth, lymphatic invasion and P53 accumulation, tumor depth and lymphatic invasion were significantly correlated with lymph node metastasis ( P =0.0023 and P =0.0092, respectively) by multivariate analysis. These data suggest that tumor depth and lymphatic invasion can be considered as good indicators for lymph node metastasis among patients with sm\u2010ESCC. In addition, P53 accumulation could be helpful to identify the patients who need additional treatment after EMR."
}